SCHEMBL7819909

SCHEMBL7819909

CCOC(=O)C1CNc2cc(F)ccc2O1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.46
CYP4F2 P78329 1/20 0.46
CYP4A11 Q02928 1/20 0.46
KMT2A Q03164 5/20 0.45
HPGD P15428 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.44
POLB P06746 1/20 0.42
ALDH1A1 P00352 4/20 0.40
TDP1 Q9NUW8 1/20 0.40
MEN1 O00255 3/20 0.38
ATF4 P18848 1/20 0.35
KDM4E B2RXH2 1/20 0.35
NPC1 O15118 1/20 0.35
MAPT P10636 1/20 0.35
RAB9A P51151 1/20 0.35
CPT1A P50416 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12850374 0.90 CYP4F2 (0.43) HSD17B10CYP4F2CYP4A11KMT2AHPGD
SCHEMBL7817820 0.87 HSD17B10 (0.60) HSD17B10CYP4F2CYP4A11KMT2AHPGD
Hydrochloric Acid SCHEMBL11562060 0.86 HSD17B10 (0.59) HSD17B10CYP4F2CYP4A11KMT2AHPGD
SCHEMBL13675536 0.85 HSD17B10 (0.46) HSD17B10CYP4F2CYP4A11KMT2AHPGD
SCHEMBL3353094 0.85 POLB (0.55) HSD17B10CYP4F2CYP4A11KMT2AHPGD
SCHEMBL29527171 0.85 POLB (0.55) HSD17B10CYP4F2CYP4A11KMT2AHPGD
SCHEMBL750101 0.85 HSD17B10 (0.46) HSD17B10CYP4F2CYP4A11KMT2AHPGD
SCHEMBL17447882 0.85 CYP4F2 (0.42) HSD17B10CYP4F2CYP4A11KMT2AHPGD
SCHEMBL29540597 0.85 CYP4F2 (0.42) HSD17B10CYP4F2CYP4A11KMT2AHPGD
SCHEMBL538597 0.84 HSD17B10 (0.44) HSD17B10CYP4F2CYP4A11KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106687446-B 5-amino-4-carbamoyl-pyrazole compounds as selective and irreversible kinase inhibitors of T790M/WT-EGFR and uses thereof 百济神州(北京)生物科技有限公司 2020-04-28 CN disclosed
WO-2016008411-A1 5-AMINO-4-CARBAMOYL-PYRAZOLE COMPOUNDS AS SELECTIVE AND IRREVERSIBLE T790M OVER WT-EGFR KINASE INHIBITORS AND USE THEREOF BEIGENE, LTD. (KY) 2016-01-21 WO disclosed
WO-2016008411-A1 5-AMINO-4-CARBAMOYL-PYRAZOLE COMPOUNDS AS SELECTIVE AND IRREVERSIBLE T790M OVER WT-EGFR KINASE INHIBITORS AND USE THEREOF BEIGENE, LTD. (KY) 2016-01-21 WO disclosed
EP-0894796-B1 Imidazolines substituted with a heterocyclic ring as alpha-2 antagonists ADIR (FR) 2001-06-06 EP disclosed
US-6057317-A Heterocyclic compounds ADIR ET COMPAGNIE (FR) 2000-05-02 US disclosed
EP-0894796-A1 Imidazolines substituted with a heterocyclic ring as alpha-2 antagonists ADIR ET COMPAGNIE (FR) 1999-02-03 EP disclosed